Coronavirus Vaccine Act

Bill: 116-s-3370
Sponsor: full_name: Sen. Markey, Edward J. [D-MA]
Introduced: 2020-03-02
Policy area: Health
Subjects: Cardiovascular and respiratory health

Emergency medical services and trauma care

Health programs administration and funding

Immunology and vaccination

Infectious and parasitic diseases

Medical research

Research administration and funding
Latest action: action_date: 2020-03-02
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2020-03-02
action_desc: Introduced in Senate
text: <p><b>Coronavirus Vaccine Act</b></p> <p>This bill directs the National Institute of Allergy and Infectious Diseases to conduct or support research to develop a coronavirus vaccine. <br /></p>

tv_txt: II 116th CONGRESS 2d Session S. 3370 IN THE SENATE OF THE UNITED STATES March 2, 2020 Mr. Markey introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To conduct or support further comprehensive research for the creation of a universal coronavirus vaccine.

1. Short title This Act may be cited as the Coronavirus Vaccine Act . 2. Research for the creation of a universal coronavirus vaccine (a) In general The Director of the National Institute of Allergy and Infectious Diseases shall conduct or support comprehensive research for the creation of a universal coronavirus vaccine. (b) Authorization of appropriations To carry out this section, there are authorized to be appropriated $250,000,000 for each of fiscal years 2020 through 2023.